IFN-β-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis

Acta Neuropathologica

Volumn 134, Issue 4, 2017, Pages 655-666

  Meyer, Alain ^a,b   Laverny, Gilles ^b,c   Allenbach, Yves ^d   Grelet, Elise ^b,c   Ueberschlag, Vanessa ^b,c   Echaniz Laguna, Andoni ^a   Lannes, Béatrice ^a   Alsaleh, Ghada ^b   Charles, Anne Laure ^a,b   Singh, François ^a,b   Zoll, Joffrey ^a,b   Lonsdorfer, Evelyne ^a,b   Maurier, François ^e   Boyer, Olivier ^f   Gottenberg, Jacques Eric ^a,b   Nicot, Anne Sophie ^b,c   Laporte, Jocelyn ^b,c   Benveniste, Olivier ^d   Metzger, Daniel ^b,c   Sibilia, Jean ^a,b   Geny, Bernard ^a,b   more..

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c CNRS   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e Hôpital Belle Isle   (France)

^f UNIVERSITÉ DE ROUEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPRAZOLAM; ATENOLOL; BETA INTERFERON; CXCL9 CHEMOKINE; ETODOLAC; FLUOXETINE; IBUPROFEN; INTERFERON; INTERLEUKIN 6; LEVOTHYROXINE; MITOCHONDRIAL PROTEIN; MYXOVIRUS RESISTANCE PROTEIN A; PARACETAMOL; REACTIVE OXYGEN METABOLITE; SUCCINATE DEHYDROGENASE; TRAMADOL; TUMOR NECROSIS FACTOR; CYTOKINE; FREUND ADJUVANT; SCAVENGER; TRANSCRIPTOME;

ADULT; AEROBIC CAPACITY; AGED; ANIMAL EXPERIMENT; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DELTOID MUSCLE; DERMATOMYOSITIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTROMYOGRAPHY; ELECTRON MICROSCOPY; ELECTRON SPIN RESONANCE; EXERCISE; FEMALE; GENE EXPRESSION; GRIP STRENGTH; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MIDDLE AGED; MITOCHONDRIAL RESPIRATION; MOUSE; MUSCLE BIOPSY; MUSCLE INJURY; MUSCLE MITOCHONDRION; MUSCLE WEAKNESS; MYOBLAST CELL LINE; MYOSITIS; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CELL LINE; DRUG EFFECT; EXPERIMENTAL CNS AUTOIMMUNE DISEASE; INFLAMMATION; METABOLISM; MITOCHONDRION; PATHOLOGY; SKELETAL MUSCLE;

ACETYLCYSTEINE; ADULT; AGED; ANIMALS; CELL LINE; CYTOKINES; DERMATOMYOSITIS; FEMALE; FREE RADICAL SCAVENGERS; FREUND'S ADJUVANT; HUMANS; INFLAMMATION; INTERFERON-BETA; MALE; MICE, INBRED BALB C; MIDDLE AGED; MITOCHONDRIA; MUSCLE WEAKNESS; MUSCLE, SKELETAL; NERVOUS SYSTEM AUTOIMMUNE DISEASE, EXPERIMENTAL; REACTIVE OXYGEN SPECIES; TRANSCRIPTOME;

EID: 85020523479     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-017-1731-9     Document Type: Article

References (51)

1. Ablasser A, Bauernfeind F, Hartmann G, Latz E, Fitzgerald KA, Hornung V (2009) RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 10:1065–1072. doi:10.1038/ni.1779
2. Alemo Munters L, Dastmalchi M, Katz A, Esbjörnsson M, Loell I, Hanna B et al (2013) Improved exercise performance and increased aerobic capacity after endurance training of patients with stable polymyositis and dermatomyositis. Arthritis Res Ther 15:R83. doi:10.1186/ar4263
3. Alexanderson H, Munters LA, Dastmalchi M, Loell I, Heimbürger M, Opava CH et al (2014) Resistive home exercise in patients with recent-onset polymyositis and dermatomyositis—a randomized controlled single-blinded study with a 2-year followup. J Rheumatol 41:1124–1132. doi:10.3899/jrheum.131145
4. Alhatou MI, Sladky JT, Bagasra O, Glass JD (2004) Mitochondrial abnormalities in dermatomyositis: characteristic pattern of neuropathology. J Mol Histol 35:615–619. doi:10.1007/s10735-004-2194-6
5. Allenbach Y, Solly S, Grégoire S, Dubourg O, Salomon B, Butler-Browne G et al (2009) Role of regulatory T cells in a new mouse model of experimental autoimmune myositis. Am J Pathol 174:989–998. doi:10.2353/ajpath.2009.080422
6. Barbasso Helmers S, Dastmalchi M, Alexanderson H, Nennesmo I, Esbjörnsson M, Lindvall B et al (2007) Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies. Ann Rheum Dis 66:1276–1283. doi:10.1136/ard.2006.058644
7. Bourji K, Meyer A, Chatelus E, Pincemail J, Pigatto E, Defraigne J-O et al (2015) High reactive oxygen species in fibrotic and nonfibrotic skin of patients with diffuse cutaneous systemic sclerosis. Free Radic Biol Med 87:282–289. doi:10.1016/j.freeradbiomed.2015.07.002
8. Brand MD, Nicholls DG (2011) Assessing mitochondrial dysfunction in cells. Biochem J 435:297–312. doi:10.1042/BJ20110162
9. Campos Y, Arenas J, Cabello A, Gomez-Reino JJ (1995) Respiratory chain enzyme defects in patients with idiopathic inflammatory myopathy. Ann Rheum Dis 54:491–493
10. Chariot P, Ruet E, Authier FJ, Labes D, Poron F, Gherardi R (1996) Cytochrome c oxidase deficiencies in the muscle of patients with inflammatory myopathies. Acta Neuropathol (Berl) 91:530–536
11. Charles A-L, Meyer A, Dal-Ros S, Auger C, Keller N, Ramamoorthy TG et al (2013) Polyphenols prevent ageing-related impairment in skeletal muscle mitochondrial function through decreased reactive oxygen species production. Exp Physiol 98:536–545. doi:10.1113/expphysiol.2012.067496
12. Dalakas MC (2015) Inflammatory muscle diseases. N Engl J Med 372:1734–1747. doi:10.1056/NEJMra1402225
13. Dembélé D, Kastner P (2014) Fold change rank ordering statistics: a new method for detecting differentially expressed genes. BMC Bioinform 15:14. doi:10.1186/1471-2105-15-14
14. Dorph C, Englund P, Nennesmo I, Lundberg IE (2006) Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis. Ann Rheum Dis 65:1565–1571. doi:10.1136/ard.2005.051086
15. Dubowitz V, Sewry C, Oldfors A (2013) Histological and histochemical stains and reactions. In: Muscle biopsy: a practical approach
16. Gali Ramamoorthy T, Laverny G, Schlagowski A-I, Zoll J, Messaddeq N, Bornert J-M et al (2015) The transcriptional coregulator PGC-1β controls mitochondrial function and anti-oxidant defence in skeletal muscles. Nat Commun 6:10210. doi:10.1038/ncomms10210
17. Gitiaux C, Kostallari E, Lafuste P, Authier F-J, Christov C, Gherardi RK (2013) Whole microvascular unit deletions in dermatomyositis. Ann Rheum Dis 72:445–452. doi:10.1136/annrheumdis-2012-201822
18. Gono T, Kaneko H, Kawaguchi Y, Hanaoka M, Kataoka S, Kuwana M et al (2014) Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease. Rheumatology 53:2196–2203. doi:10.1093/rheumatology/keu258
19. Greenberg SA (2010) Type 1 interferons and myositis. Arthritis Res Ther 12(Suppl 1):S4. doi:10.1186/ar2885
20. Greenberg SA, Pinkus JL, Pinkus GS, Burleson T, Sanoudou D, Tawil R et al (2005) Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 57:664–678. doi:10.1002/ana.20464
21. Hassan AB, Fathi M, Dastmalchi M, Lundberg IE, Padyukov L (2006) Genetically determined imbalance between serum levels of tumour necrosis factor (TNF) and interleukin (IL)-10 is associated with anti-Jo-1 and anti-Ro52 autoantibodies in patients with poly- and dermatomyositis. J Autoimmun 27:62–68. doi:10.1016/j.jaut.2006.06.003
22. Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR et al (2004) 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord NMD 14:337–345. doi:10.1016/j.nmd.2004.02.006
23. Kuznetsov AV, Veksler V, Gellerich FN, Saks V, Margreiter R, Kunz WS (2008) Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells. Nat Protoc 3:965–976. doi:10.1038/nprot.2008.61
24. Lejay A, Meyer A, Schlagowski A-I, Charles A-L, Singh F, Bouitbir J et al (2014) Mitochondria: mitochondrial participation in ischemia-reperfusion injury in skeletal muscle. Int J Biochem Cell Biol 50:101–105. doi:10.1016/j.biocel.2014.02.013
25. Liao AP, Salajegheh M, Nazareno R, Kagan JC, Jubin RG, Greenberg SA (2011) Interferon β is associated with type 1 interferon-inducible gene expression in dermatomyositis. Ann Rheum Dis 70:831–836. doi:10.1136/ard.2010.139949
26. Loell I, Raouf J, Chen Y-W, Shi R, Nennesmo I, Alexanderson H et al (2016) Effects on muscle tissue remodeling and lipid metabolism in muscle tissue from adult patients with polymyositis or dermatomyositis treated with immunosuppressive agents. Arthritis Res Ther 18:136. doi:10.1186/s13075-016-1033-y
27. Miró O, Casademont J, Grau JM, Jarreta D, Urbano-Márquez A et al (1998) Histological and biochemical assessment of mitochondrial function in dermatomyositis. Br J Rheumatol 37:1047–1053
28. Mitsui T, Azuma H, Nagasawa M, Iuchi T, Akaike M, Odomi M et al (2002) Chronic corticosteroid administration causes mitochondrial dysfunction in skeletal muscle. J Neurol 249:1004–1009. doi:10.1007/s00415-002-0774-5
29. Murray SG, Schmajuk G, Trupin L, Lawson E, Cascino M, Barton J et al (2015) A population-based study of infection-related hospital mortality in patients with dermatomyositis/polymyositis. Arthritis Care Res 67:673–680. doi:10.1002/acr.22501
30. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE (2002) Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346:793–801. doi:10.1056/NEJMoa011858
31. Prescott LF, Park J, Ballantyne A, Adriaenssens P, Proudfoot AT (1977) Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet Lond Engl 2:432–434
32. Reed AM, Peterson E, Bilgic H, Ytterberg SR, Amin S, Hein MS et al (2012) Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course. Arthritis Rheum 64:4078–4086. doi:10.1002/art.34659
33. Rice GI, Forte GMA, Szynkiewicz M, Chase DS, Aeby A, Abdel-Hamid MS et al (2013) Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. Lancet Neurol 12:1159–1169. doi:10.1016/S1474-4422(13)70258-8
34. Salajegheh M, Kong SW, Pinkus JL, Walsh RJ, Liao A, Nazareno R et al (2010) Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy. Ann Neurol 67:53–63. doi:10.1002/ana.21805
35. Sasaki M, Ikeda H, Sato Y, Nakanuma Y (2008) Proinflammatory cytokine-induced cellular senescence of biliary epithelial cells is mediated via oxidative stress and activation of ATM pathway: a culture study. Free Radic Res 42:625–632. doi:10.1080/10715760802244768
36. Seifert U, Bialy LP, Ebstein F, Bech-Otschir D, Voigt A, Schröter F et al (2010) Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 142:613–624. doi:10.1016/j.cell.2010.07.036
37. Singh F, Charles A-L, Schlagowski A-I, Bouitbir J, Bonifacio A, Piquard F et al (2015) Reductive stress impairs myoblasts mitochondrial function and triggers mitochondrial hormesis. Biochim Biophys Acta 1853:1574–1585. doi:10.1016/j.bbamcr.2015.03.006
38. Somani A-K, Swick AR, Cooper KD, McCormick TS (2008) Severe dermatomyositis triggered by interferon beta-1a therapy and associated with enhanced type I interferon signaling. Arch Dermatol. doi:10.1001/archderm.144.10.1341
39. Srinivasan S, Avadhani NG (2012) Cytochrome c oxidase dysfunction in oxidative stress. Free Radic Biol Med 53:1252–1263. doi:10.1016/j.freeradbiomed.2012.07.021
40. Suárez-Calvet X, Gallardo E, Nogales-Gadea G, Querol L, Navas M, Díaz-Manera J et al (2014) Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis. J Pathol 233:258–268. doi:10.1002/path.4346
41. Tal MC, Sasai M, Lee HK, Yordy B, Shadel GS, Iwasaki A (2009) Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proc Natl Acad Sci USA 106:2770–2775. doi:10.1073/pnas.0807694106
42. Teunissen PFA, Boshuizen MC, Hollander MR, Biesbroek PS, van der Hoeven NW, Mol J-Q et al (2015) MAb therapy against the IFN-α/β receptor subunit 1 stimulates arteriogenesis in a murine hindlimb ischaemia model without enhancing atherosclerotic burden. Cardiovasc Res 107:255–266. doi:10.1093/cvr/cvv138
43. Turrens JF (2003) Mitochondrial formation of reactive oxygen species. J Physiol 552:335–344. doi:10.1113/jphysiol.2003.049478
44. Varadhachary AS, Weihl CC, Pestronk A (2010) Mitochondrial pathology in immune and inflammatory myopathies. Curr Opin Rheumatol 22:651–657. doi:10.1097/BOR.0b013e32833f108a
45. Wedderburn LR, Varsani H, Li CKC, Newton KR, Amato AA, Banwell B, Bove KE et al (2007) International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. Arthritis Rheum 57:1192–1201. doi:10.1002/art.23012
46. West AP, Khoury-Hanold W, Staron M, Tal MC, Pineda CM, Lang SM et al (2015) Mitochondrial DNA stress primes the antiviral innate immune response. Nature. doi:10.1038/nature14156
47. West AP, Shadel GS, Ghosh S (2011) Mitochondria in innate immune responses. Nat Rev Immunol 11:389–402. doi:10.1038/nri2975
48. Wiesinger GF, Quittan M, Nuhr M, Volc-Platzer B, Ebenbichler G, Zehetgruber M et al (2000) Aerobic capacity in adult dermatomyositis/polymyositis patients and healthy controls. Arch Phys Med Rehabil 81:1–5
49. Woo M, Chung SJ, Nonaka I (1988) Perifascicular atrophic fibers in childhood dermatomyositis with particular reference to mitochondrial changes. J Neurol Sci 88:133–143
50. Zoll J, Koulmann N, Bahi L, Ventura-Clapier R, Bigard A-X (2003) Quantitative and qualitative adaptation of skeletal muscle mitochondria to increased physical activity. J Cell Physiol 194:186–193. doi:10.1002/jcp.10224
51. Zoll J, Sanchez H, N’Guessan B, Ribera F, Lampert E, Bigard X et al (2002) Physical activity changes the regulation of mitochondrial respiration in human skeletal muscle. J Physiol 543:191–200